BOT 1.54% 32.0¢ botanix pharmaceuticals ltd

Ann: Botanix to Present at Euroz Hartleys Conference, page-94

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,217 Posts.
    lightbulb Created with Sketch. 1564
    I think the problem we have (which is a good problem, not a bad one) is that the exceptional value lies in the pipeline BOT have, which I'm not sure another party is prepared to pay for yet. Sofdra will be the cash cow that supports developing acne, AM, and rosacea through to approval and market. So if BOT are going to sell Sofdra alone, it'd have to be for +$2 to make it viable to progress everything else. Admittedly, that is only $2bUSD, which I think would be good value to BP for the planet's superior AH product and a global licence on it.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.005(1.54%)
Mkt cap ! $581.5M
Open High Low Value Volume
32.5¢ 33.0¢ 32.0¢ $1.058M 3.280M

Buyers (Bids)

No. Vol. Price($)
2 147750 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 632850 6
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.